
Alsatinib Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Dasatinib (100mg)
Overview Alsatinib Tablet
Alectinib tablets are indicated for the management of chronic myeloid leukemia (CML). This medication is prescribed for patients whose CML has proven unresponsive to, or is intolerable due to side effects from, other leukemia therapies. Alectinib can be administered with or without food, but consistent daily timing optimizes therapeutic efficacy. Dosage and frequency are determined by your physician, based on your individual needs and may be adjusted. Strict adherence to your doctor's instructions is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, requiring several weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate, and elevated or decreased blood pressure, while less frequent, necessitate immediate medical attention. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking alectinib. This medication can lower blood cell counts, increasing infection risk; regular blood tests are therefore essential. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Alectinib is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances occur.
Primary Ingredients of Alsatinib Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Alsatinib Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Alsatinib Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alsatinib tablets can be taken with or without food, though consistent timing is recommended.
Common Side effects of Alsatinib Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Alsatinib Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Alsatinib Tablet whole; avoid crushing, chewing, or breaking it. It can be taken with or without food, but consistency in timing is recommended.
How Alsatinib Tablet works:
Alsatinib tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for driving cancer cell proliferation, thus hindering or arresting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Alsatinib Tablet may pose unknown safety risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Taking Alsatinib tablets during pregnancy poses a confirmed risk to the fetus. While rarely prescribed, a physician might consider its use only in life-threatening circumstances where potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
The use of Alsatinib tablets while breastfeeding is contraindicated. Available evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Alsatinib Tablet side effects. Exercise caution while driving if dizziness or blurred vision occurs after taking Alsatinib Tablet.
KidneySAFE IF PRESCRIBED
The use of Alsatinib tablets in patients with kidney disease appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely take Alsatinib tablets without requiring any alteration to the prescribed dosage.
What if you forget to take Alsatinib Tablet :
Omit any missed Alsatinib Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Alsatinib Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | TKIs |
